PLUS vs TMO
ePlus inc (PLUS) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
PLUS currently screens at market cap $2.10B and trailing P/E 17.1. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the PLUS and TMO stock pages for the full models.
Not investment advice.